GW
Glenn Whaley
Chief Financial Officer

Glenn Whaley insider trades: Immunic (IMUX) stock purchases

Chief Financial Officer, Immunic Last trade Jun 3, 2025 24 Form 4 filings
$0
Sold, last 12 months
0 sales
$0
Bought, last 12 months
0 buys
8
Open-market trades
since 2020
2
Companies
last trade 2025

Trades on the price chart

Daily close, with an arrow on each day they bought or sold

Companies

Where Glenn reports to the SEC

Open-market buys and sales

8 trades reported on SEC Form 4, newest first

DateStockTypeValue
Jun 3, 2025IMUX↑ Buy$32K
May 15, 2023IMUX↑ Buy$9K
Nov 7, 2022IMUX↑ Buy$7K
Jun 3, 2022IMUX↑ Buy$11K
May 12, 2022IMUX↑ Buy$15K
Aug 10, 2021IMUX↑ Buy$15K
Mar 2, 2021IMUX↑ Buy$16K
Aug 10, 2020IMUX↑ Buy$19K

Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.

About Glenn Whaley's insider trades

Glenn Whaley is Chief Financial Officer at Immunic (IMUX). Since Aug 10, 2020, Glenn has reported 8 open-market purchases worth $124K and no sales on SEC Form 4. There have been no open-market trades in the last 12 months.

Their filings also include grants and awards (16 filings), shares returned to the company (1 filing), shares withheld for taxes (1 filing). These aren't open-market trades and aren't counted above.

How to read insider trades

Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every IMUX insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.